FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:672 August 31, 2000 Number 9

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kovacs, J. A.

Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection . On page 1421, beginning on the first line of the right-hand column, the dose of the double-strength tablet should have read, "160 mg of trimethoprim plus 800 mg of sulfamethoxazole," not "80 mg of trimethoprim plus 400 mg of sulfamethoxazole," as printed, and the dose of the single-strength tablet should have read, "80 mg of trimethoprim plus 400 mg of sulfamethoxazole," not "40 mg of trimethoprim plus 200 mg of sulfamethoxazole," as printed. Also, in Table 2, next to the entry "Isoniazid-resistant source case . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.